Biomaterials, 2012 · DOI: 10.1016/j.biomaterials.2011.11.002 · Published: February 1, 2012
This study explores a new way to treat spinal cord injuries by combining a physical support structure with gene therapy. The support, called a bridge, helps stabilize the injury and guide the growth of nerve fibers. The researchers loaded these bridges with lentivirus that can deliver genes encoding for neurotrophic factors (NT3 or BDNF). These factors are known to help nerve cells survive and grow. The results showed that this combined approach significantly increased the growth of nerve fibers into the bridge and promoted the formation of myelin, a protective coating around nerve fibers, leading to enhance axonal growth and promote regeneration.
The delivery of neurotrophic factors via lentivirus-loaded bridges can significantly enhance axon regeneration after spinal cord injury.
The induced expression of NT3 and BDNF can promote myelination of axons within the channels of the bridge, improving nerve function.
The lentivirus delivery system allows for localized and sustained transgene expression at the injury site, minimizing off-target effects.